Skip to main content
Log in

Effects of aurothioglucose and auranofin on radiographic progression in rheumatoid arthritis

  • Originals
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

Radiographic films of 40 patients participating in a single centre patient blind study of auranofin versus aurothioglucose were evaluated in a random order by one reader. The two treatment groups were comparable with respect to number of erosions and total radiographic score at the start of the study. Only in the auranofin-treated patients was a statistically significant increase in the mean number of new erosions (p<0.001 at 6 months and p<0.01 at 12 months treatment, paired t-test) as well as in the total radiographic score (p<0.01 at 6 and 12 months treatment, paired t-test) observed. Results of this study confirm that parenteral gold compounds do retard radiographic progression of joint destruction in the treatment of rheumatoid arthritis. The effects on radiographic progression shown in this study are in agreement with other reports which, based on clinical and biochemical parameters, have shown that auranofin is somewhat less effective than the injectible gold salts.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sigler, J.W., Bluhm, G.B., Duncan, H. et al. Gold salts in the treatment of rheumatoid arthritis: a double blind study. Ann Intern Med 1974, 80, 21–6.

    PubMed  CAS  Google Scholar 

  2. Luukkainen, R. Chrysotherapy in rheumatoid arthritis: with particular emphasis on the effect of chrysotherapy on radiographic changes and on the optimal time of initiation of therapy. Scand J Rheumatol (suppl) 1980, 34, 1–56.

    CAS  Google Scholar 

  3. Cooperating Clinics Committee of the American Rheumatism Association. A controlled trial of gold salt therapy in rheumatoid arthritis. Arthritis Rheum 1973, 16, 353–8.

    Google Scholar 

  4. Cooperating Clinics Committee of the American Rheumatism Association. A controlled trial of cyclophosphamide in rheumatoid arthritis. N Engl J Med 1970, 283, 883–9.

    Article  Google Scholar 

  5. Lewis, D., Capell, H.A. Oral gold: A comparison with placebo and with intramuscular sodium aurothiomalate. Clin Rheumatol 1984, 3 (suppl 1), 83–95.

    PubMed  Google Scholar 

  6. Van Riel, P.L.C.M., Van de Putte, L.B.A., Gribnau, F.W.J., et al. Comparison of auranofin and aurothioglucose in the treatment of rheumatoid arthritis: a single blind study, Clin Rheumatol 1984, 3 (suppl 1), 51–6.

    PubMed  Google Scholar 

  7. Ward, J.R., Williams, H.J., Egger, M.J., et al. Comparison of auranofin, gold sodium thiomalate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum, 1983, 26, 1303–15.

    PubMed  CAS  Google Scholar 

  8. Gofton, J.P., O'Brien, W.M., Hurley, J.N., et al. Radiographic evaluation of erosions in rheumatoid arthritis: double-blind study of auranofin vs placebo. J Rheumatol 1984, 11, 768–71.

    PubMed  CAS  Google Scholar 

  9. Larsen, A., Horton, J., Osborne, C. Auranofin compared with intramuscular gold in the long-term treatment of rheumatoid arthritis: an X-ray analysis. In: Auranofin Proceedings of a Smith, Kline & French International Symposium. Editors: Capell, A., Cole, D.S., Manghani, K.K., Morris, R.W. Amsterdam. Excerpta Medica 1983, 264–74.

    Google Scholar 

  10. Ropes, M.W. Diagnostic criteria for rheumatoid arthritis 1958 revision. Ann Rheum Dis 1959, 18, 49–51.

    Article  Google Scholar 

  11. Larsen, A. Radiographic evaluation of rheumatoid arthritis in therapeutic trials. In: Controversies in the Clinical Evaluation of Analgesic — Anti-inflammatory — Antirheumatic drugs. Editors: Paulus, H.E., Ehrlich, G.E., Lindenlaub, E. Lindenlaub, F.K. Schatteurer Verlag, Stuttgart 1981, 323–9.

    Google Scholar 

  12. Larsen, A., Dale, K. Standardized radiological evaluation of rheumatoid arthritis in therapeutic trials. In: Recognition of Antirheumatic Drugs. Editors: Dumonde, D.C., Jasani, J.K. MTP-Press, Lancaster 1978, 285–92.

    Google Scholar 

  13. Larsen, A., Dale, K., Eek, M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 1977, 18, 481–91.

    CAS  Google Scholar 

  14. Forestier, J. Rheumatoid arthritis and its treatment by gold salts. J Lab Clin Med 1935, 20, 827–9.

    Google Scholar 

  15. Amos, R.S., Constable, T.J., Crockson, R.A., et al. Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes. Br Med J 1977, 1, 195–7.

    Article  PubMed  CAS  Google Scholar 

  16. Sjöblom, K.G., Saxne, T., Pettersson, H., et al. Factors related to the progression of joint destruction in rheumatoid arthritis. Scand J Rheumatol 1984, 13, 21–7.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Van Riel, P.L.C.M., Larsen, A., Van De Putte, L.B.A. et al. Effects of aurothioglucose and auranofin on radiographic progression in rheumatoid arthritis. Clin Rheumatol 5, 359–364 (1986). https://doi.org/10.1007/BF02054254

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02054254

Key words

Navigation